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ABSTRACT
 The purpose of this study is to determine the characteristics of liposome Caesalpinia Sappan 
wood ethyl acetate fraction (SWEAF) as an active compound. Liposome was prepared by using two 
methods: Thin Layer Hydration (TLH) and Reversed Phase Evaporation (REV) methods. Liposome 
composition was 1 part of the SWEAF and 6 parts of the liposome component (phosphatidyl choline 
and cholesterol with an equally large molar ratio). Both methods produce red-colored liposome 
dispersion. When examined with transmission electrone microscope, both methods yielded a spherical 
and unilamellar liposome. The TLH method produces liposome with a particle size of 2,304.5 ± 528.9 
nm. The REV method yields a liposome with a particle size of 2,643.5 ± 350.8 nm. The polydispersity 
index shows the distribution of liposome size. The TLH method produces liposome with a polydispersity 
index of 1,490 ± 0.284. The REV method produces liposome with a polydispersity index of  
1.987 ± 0.901. 
Keywords: Caesalpinia sappan L., Liposome, Thin Layer Hydration method,
 Reversed Phase Evaporation method.
INTRODUCTION
 The increased incidence of adverse 
drug-induced side effects has not only incited the 
researcher to look for new drugs that are safe 
to use, but also to find ways to deliver the drug 
well. A drug delivery system is needed to deliver 
the drug directly to the target without disturbing 
the surrounding environment, thus reducing side 
effects and improving the effect of the drug. Some 
of the existing drug delivery systems are nio 
some, resealed erythrocytes, pharmacosomes, 
and liposome. Among the drug delivery systems, 
liposome is one of the fastest growths1,2,3.
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  The liposome is a round vesicle having a 
water core portion surrounded by one or more lipid 
concentrates to form a double layer lipid membrane. 
Due to its unique structure, liposome can be used 
to deliver water and fat soluble drug molecules. 
Hydrophilic molecules are present in compartments 
containing water and lipophilic molecules in double 
layer fat4,5,6.
 Liposome is a good drug del ivery 
system because it has characteristics such as 
biodegradable, non-toxic, flexible that can deliver 
both hydrophilic and lipophilic drugs, increase 
efficacy and therapeutic index, and improve drug 
stability through encapsulation7. Liposome has 
been widely used as a drug delivery system such 
as anticancer drugs8, antibacterials9, antifungals10, 
vaccines11, and medications for asthma12. Liposome 
is not only can be used as a drug delivery system in 
synthetic drugs but it can also be used as a system 
of delivery of compounds from plants that can be 
utilized in treatment13.
 Research on medicinal plants and new 
medicines derived from nature has increased over 
the past four decades. This can be attributed to 
the fact that the available synthetic drugs are too 
expensive and tend to carry unwanted side effects14. 
One plant that has been widely used for treatment 
is Sappan (Caesalpinia sappan L.).
 Sappan (Caesalpinia sappan L.) is a 
widespread plant of the Caesalpiniaceae family 
in Southeast Asia. This plant has been used 
for anti-inflammatory15, hepatoprotective16, anti 
influenza17, antioxidant, antelmintic14, analgesic18, 
and immunomodulator19. Caesalpinia sappan L is 
also potential for cancer treatment20,21.
 Components of active compounds contained 
in Caesalpinia sappan L. are brazillin, brazilein, 
sapanon, kalkon, sapankalkon and other common 
components, such as amino acids, carbohydrates 
and palmitic acid which are relatively small amounts22. 
The wood part of Caesalpinia sappan L. contains 
phenolic compounds such as 4-O-methylsappanol, 
protosappanin A, protosappanin B, brazilin, brazilein, 
and sapankalkon23. Brazilin is the main active ingredient 
found in the wood of Caesalpinia sappan L. 24. Plants 
that contain many phenolics are known to have 
high antioxidant activity because it can capture free 
radicals and inhibit the enzyme responsible for the 
formation of free radicals25,26. But its use is limited 
due to polyphenol instability27. 
 Because the nature of the compounds 
contained in the wood is unstable, a method that can 
maintain its stability is required. One such method 
is by using liposome. This study aims to determine 
the characteristics of liposomes made using two 
methods including organoleptis, morphology, particle 
size and particle size distribution.
MATERIALS AND METHODS
Materials
 Caesalpinia sappan L. wood was collected 
in Solo, Central Java, Indonesia. Phosphatidylcholine 
and cholesterol were purchase from Sigma-Aldrich, 
Singapore. chloroform, n-hexane, ethyl acetate and 
ethanol bought from Merck & Co, German. Potassium 
dihydrogen phosphate, sodium hydroxide and 
aquadest were bought from Brataco, Indonesia
Preparation of SWEAF 
 Caesalpinia sappan L. wood were dried 
and ground into a fine powder, and then extraced 
with 70 % ethanol at room temperature for 3 days. 
The combined filtrate was collected three times by 
filter paper, and the solvent was evaporated using 
a rotary evaporator to obtain a thickened Sappan 
wood extract.  A total of 40.05 g of viscous Sappan 
wood extract was dissolved in 500 mL of ethanol 
and 500 mL of water. After forming a clear solution 
of reddish-brown, ethanol was evaporated using a 
rotary evaporator. After all ethanol has evaporated, 
the water containing the wood extract Sappan was 
inserted into the separating funnel then fractionated 
with n-hexane solvent with a ratio of 1 : 1 solvent 
(500 mL : 500 mL). The separating funnel was then 
shaken to mix both water solvents and n-hexane, 
after which it was left so that there were two layers 
of water and n-hexane. The fractionation with 
the n-hexane solvent was performed until a clear 
n-hexane was obtained. Furthermore, the water layer 
was fractionated with ethyl acetate in a ratio of 1: 1 
(500 mL : 500 mL) to obtain two layers of water and 
ethyl acetate. The fractionation process with ethyl 
acetate was carried out until a clear layer of ethyl 
acetate. The SWEAF was concentrated with a rotary 
evaporator to obtain a thick ethyl acetate fraction.
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Preparation of Liposome
The Thin Layer Hydration Method
 The phosphatidylcholine, cholesterol and 
SWEAF were weighted by the amount according 
to the formula shown in Table 1. Cholesterol (mg) 
and phosphatidylcholine (mg) were dissolved in 
10 mL of chloroform. The solvent was then evaporated 
using a rotary evaporator at 50 °C. The solvent was 
evaporated to form a thin layer on the bottom wall of 
the flask, which is a lipid layer of liposomes. The lipid 
layer formed was hydrated with 10 mL of a phosphate 
buffer solution of pH 7.4 containing SWEAF. Rotary 
evaporator was ignited without vacuum for 1 h until 
multilamellar vesicle liposome (MLV) was formed. 
The liposome obtained was then synchronized with 
a sonicator bath for 45 min. in order to size into a 
small unilamellar vesicle (SUV)13,28,29.
The Reverse Phase Revealing Method
 The phosphatidylcholine, cholesterol and 
SWEAF were weighted by the amount according to 
the formula shown in Table 1. Phosphatidylcholine 
(mg) and cholesterol (mg) were dissolved in 
30 ml of chloroform. The SWEAF was dissolved in 
10 mL phosphate buffer solution pH 7.4. Then the 
two phases were mixed and sonicated with bath 
sonicator for 10 minutes. The result of sonication 
was inserted into the flask, then the solvent was 
evaporated with a rotary evaporator at 50 °C to 
obtain liposome30,31,32.
Evaluation of Liposomes
1. Organoleptic Examination
 The liposome suspension was observed 
v isual ly. The resul ts obtained were 
recorded33.
2.  Evaluation of morphology by using 
Transmission Electron Microscopy (TEM)
 The sample was dripped on a carbon coated 
cooper grid of one drop and allowed to stand 
for one minute to dry, then added one drop of 
2% acetate uranil and let stand one minute at 
room temperature, then analyzed with TEM34.
Table 1: Liposome Formula
     Liposome component
SWEAF Molar Phosphatidylcholine Cholesterol
(mg) Ratio (mg) (mg)
20 1:1 79,82 40,18
3.  Particle Size Determination and Distribution
 Evaluation was done by using Particle Size 
Analyzer (PSA) with light scattering method 
at 25 °C. Prior to measurement, the sample 
was dispersed onto the dispersing medium. 
The dispersing medium used is aquadest, 
inserted into a fluid tank. The sample was then 
slowly dripped at the baseline to determine the 
particle size of the liposomal globules 35,36.
4.  Qualitative test of the SWEAF and liposome 
with TLC
 Liposomes were centrifuged for 30 min.
at 11,000 rpm to separate supernatants 
and precipitates 13,36. The SWEAF 
absorbed (precipitate) and the SWEAF free 
(supernatant) was dropped on TLC plate to 
determine Rf value with butanol : acetic acid 
: water (2 : 0 , 5 : 2) as mobile phase.
RESULTS 
 After conducting research on the making 
of liposome with active compound of the SWEAF, it 
is revealed that.
1.  SWEAF as much as 2.51 g was obtained 
from 40.05 g of viscous Sappan wood extract 
with a yield of 6.27% by weight of viscous 
extract.
2.  The examination of organoleptic SWEAF 
shows that the fraction is thick, reddish brown, 
odorless, and bitter.
3.  The results of the making of liposomes 
with TLH and REV methods obtained red 
liposomes with an egg-like smell. The results 
are as shown in Figure 1.
4.  Examination using Transmission Electron 
Microscopy (TEM), liposomes prepared by 
TLH and REV methods have morphology of 
round and unilamellar vesicles namely water 
cores surrounded by a layer of lipid which can 
be seen in Figures 2 and 3.
5.  The results of the measurement of liposomal 
particles from the TLH and the REV methods 
show that the average size of liposome 
particles prepared by TLH method is smaller 
than the average size of liposomal particles 
prepared by REV method (Table 2). The 
results of statistical analysis with t test note 
that the liposomal particle size of the two 
methods do not differ significantly.
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6.  The result of determination of particle 
size distribution shows that the liposome 
polymerization index value of TLH method 
is smaller than liposome from REV method 
(Table 3). The result of statistical test with t 
test shows that the particle size distribution 
of both methods does not differ significantly.
7.  The results of qualitative test of the SWEAF, 
the SWEAF absorbed (precipitate) in liposome 
and the SWEAF free (supernatant) by using 
thin layer chromatography with butanol : 
acetic acid : water (2: 0, 5: 2) show three 
parallel spots that indicate that the compound 
contained in all three is the same. This can 
be seen in Figures 4 and 5.
Fig. 1. A mixture of phosphatidylcholine and 
cholesterol in chloroform and SWEAF in a 
phosphate buffer solution pH 7.4 after sonication
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Fig. 2. Morphology and liposomal lamellarity under 
TEM with TLH method (A) Magnification 40000 ×; (B) 
80000 × magnification; 1. The lipid section; 2. The 
water core part
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Fig. 3. Morphology and liposomal lamellarity under 
TEM with REV method (A) Magnification 40000 ×; 
(B) 80000 × magnification; 1. The lipid section; 2. The 
water core part
DISCUSSION
 In this research, liposome was prepared 
with active compound of SWEAF. Sappan is known 
to have high antioxidant activity25,26. The composition 
of liposome prepared can be seen in Table 1. The 
SWEAF was obtained from the fractionation of the 
viscous extract of Sappan wood. Viscous Sappan 
wood extract obtained from previous researchers. 
 In this study, the preparation of liposomes 
with active compound of SWEAF using two methods 
namely TLH method and REV method. The reason 
for choosing these two methods is that they more 
practical and simple, considering the availability of 
tools in the laboratory, and the resulting liposomes 
can absorb medication up to 65%4,29.
 Liposomal suspension resulting from 
the TLH method is as red as the color of the 
SWEAF with the egg-like smell because it uses 
phosphatidylcholine derived from the egg. The color 
of the liposomal suspension obtained depends on 
the color of the active compound used.
 The result of the observation of the 
morphology of liposomes prepared by TLH and 
REV methods shows that liposomes are round and 
unilamellar and contain core water surrounded by 
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a lipid layer which can be seen in Fig. 2 and 3. The 
results of previous studies conducted by Verawaty36, 
Naeem34, and Anabousi37 on the preparation of 
liposomes by using TLH method obtained similar 
results. Previous studies on the production of 
liposomes with REV methods conducted by 
Mishra38, Pentak39, and Moscho40 also made similar 
discovery. 
Table 2: Particle size of Liposome
Method  Diameter (nm)  Mean ± SD
 Preparation I Preparation II Preparation III
 
Thin layer 1884.5 2898.5 2130.4 2304.5 ± 528.9
hydration
Reverse phase 2843.2 2848.9 2238.4 2643.5 ± 350.8
evaporation
Table 3: Polidispersity index of Liposom
Method  Polidispersity index  Mean ± SD
 Preparation I Preparation II Preparation III
 
Thin layer 1.418 1.248 1.803 1.490 ± 0.284
hydration
Reverse phase 2.905 1.104 1.953 1.987 ± 0.901
evaporation
Fig. 4. TLC platform of liposome testing of TLH 
method; 1. SWEAF (Rf 077); 2. Precipitate (Rf 0.77); 3. 
Supernatant (Rf 0.77).
Fig. 5. TLC platform of liposome testing of REV 
method; 1. SWEAF (Rf 0.77); 2. Precipitate (Rf 0.76); 
3. Supernatant (Rf 0.77)
 Liposome particle size was obtained by 
the TLH method from the first to third preparation at 
1884.5 nm, 2898,5 nm; 2130.4 nm with an average 
of 2304.5 ± 528.9 (see Table 2). The preparation 
of liposomes with a TLH method will produce a 
liposome with Multilamellar Vesicles (MLV) type, 
which will become Small Unilamellar Vesicles (SUV) 
after the liposomal sonication process. But from 
the measurements, the liposomes obtained have a 
type of Giant Unilamellar Vesicles (GUV) where the 
liposome has a size > 1000 nm.
 The results of the evaluation of liposomal 
particle size from the TLH method performed by 
Aukunuru13 obtained liposomes with particle sizes 
above 5000 nm including Giant Unilamellar Vesicles 
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(GUV). A study conducted by Chen35 obtained a 
particle size of 785.1 nm liposomes that included 
Large Unilamellar Vesicles (LUV). A study conducted 
by Verawaty36 obtained a liposome particle size of 
the same formula of 2977.5 nm which included Giant 
Unilamellar Vesicles (GUV). The size of the liposomal 
particles obtained by the REV method from the 
first to third manufacture respectively is 2843.2 nm; 
2848.9 nm; 2238.4 nm with an average of 2643.5 
± 350.8 (Table 3). The results of the evaluation of 
liposomal particle size from the REV method by 
Elorza31 obtained 238 nm liposomes including Large 
Unilamellar Vesicles (LUV). Research conducted by 
Yang32 obtained liposomes type Large Unilamellar 
Vesicles (LUV) with a size of 206.4 nm. Further 
research conducted by Chen35 obtained liposomes 
with a particle size of 551.1 which includes Large 
Unilamellar Vesicles (LUV). The results of previous 
studies found the appropriate liposome size as 
expected, whereas the production of liposomes 
with reversed phase evaporation method yielded 
liposomes with the type of Large Unilamellar Vesicles 
(LUV) with the size of 100-1000 nm, but the results 
of liposomes measurements obtained from the 
REV method in this study has a size> 1000 nm 
belonging to the Giant Unilamellar Vesicles (GUV). 
The liposomes obtained from the TLH method have 
an average particle size smaller than the liposomes 
obtained from REV methods. The result of statistical 
analysis using t test obtained significance value of 
0.407 where the significance value of 0.05 indicates 
that the liposomes particle size of the two methods 
did not differ significantly. 
 Analysis using Particle Size Analyzer 
(PSA) also obtained polydispersity index. The 
polydispersity index is a parameter for determining 
the particle size distribution of nanoparticles. The 
range of polydispersity index values is from 0.01-0.7 
for monodispersion and > 0.7 for polydispersion41. 
The liposomal polymerisation results from the TLH 
method and the REV method give an average 
polydispersity value of 1,490 ± 0.284 and 1.987 
± 0.901. The liposomal polydispersity index of the 
TLH method is smaller than liposomes prepared by 
REV methods. The result of statistical analysis using 
t test from both methods did not differ significantly. 
The polydispersity index shows that the liposomes 
obtained from both methods are polydispersed with 
a high polydispersity value. A high polydispersity 
index indicates that the particles formed are not 
dispersed uniformly so that it tends to aggregate 
causing enlargement of the liposome particle size.
Qualitative testing of the SWEAF and liposome 
with active ingredient of SWEAF by using thin 
layer chromatography to ensure that the SWEAF is 
present in the liposome prepared. TLC plate shows 
a partial stain, which indicates that the SWEAF 
absorbed in liposome.
CONCLUSION
 Based on the results of this study, it can be 
concluded that
1. Liposomes prepared with a TLH method and 
REV methods have a red color and egg-like 
smell.
2. Examined with TEM, liposomes prepared with 
TLH and REV methods have morphologies 
of round and unilamellar vesicles.
3. Liposomes prepared with TLH method 
have smaller particle sizes than liposomes 
prepared with REV method.
4. Liposomes prepared with TLH method have 
a smaller particle size distribution than those 
prepared with REV method.
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